22157.jpg
Global Type 1 Diabetes Drug Forecast and Market Analysis Report 2021-2029 : Rise of Pump Usage and Increased Market Entry of Ultra-Rapid-Acting Insulin Formulations May Improve the Landscape
21 avr. 2021 07h13 HE | Research and Markets
Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The therapeutic market...
22157.jpg
Dementia with Diabetes Pipeline Insight Report, 2020 - Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type
04 nov. 2020 07h03 HE | Research and Markets
Dublin, Nov. 04, 2020 (GLOBE NEWSWIRE) -- The "Dementia with Diabetes - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. The "Dementia with Diabetes -...
22157.jpg
Insights on the Automated Insulin Delivery Global Market to 2024 - Featuring Medtronic & Eli Lilly and Company Among Others
28 août 2020 09h54 HE | Research and Markets
Dublin, Aug. 28, 2020 (GLOBE NEWSWIRE) -- The "Global Automated Insulin Delivery (AID) Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)" report has been added to...
logo 02.jpg
Digital Diabetes Management Market Size To Witness A CAGR Exceeding 23.7% By 2023 | Market Research Future
31 juil. 2019 02h59 HE | Market Research Future
Pune, India, July 31, 2019 (GLOBE NEWSWIRE) -- Digital Diabetes Management Market is expected to represent 23.7% CAGR over the forecast period from 2018 to 2023, report published by Market Research...
Logo (3).png
Digital Diabetes Market worth $12.03 billion by 2025- Exclusive Report by Meticulous Research®
24 juil. 2019 11h05 HE | Meticulous Market Research Pvt. Ltd.
London, July 24, 2019 (GLOBE NEWSWIRE) -- According to a new market research report “Digital Diabetes Market by Product (SMBG, CGM, Smart Insulin Pump, Smart Insulin Pens, Software, Apps), End User...
AMI.jpg
UPDATE - Global Artificial Intelligence in Diabetes Management Market is Expected to Grow at a CAGR of 37.7% in 2019-2027: Absolute Markets Insights
07 mars 2019 07h01 HE | Absolute Markets Insights
PUNE, India, March 07, 2019 (GLOBE NEWSWIRE) -- Type 2 diabetes is a chronic condition in which an individual is unable to produce or use insulin well, that subsequently results in elevated blood...
AMI.jpg
Global Artificial Intelligence in Diabetes Management Market is Expected to Grow at a CAGR of 37.7% in 2019-2027: Absolute Markets Insights
06 mars 2019 07h29 HE | Absolute Markets Insights
PUNE, India, March 06, 2019 (GLOBE NEWSWIRE) -- Type 2 diabetes is a chronic condition in which an individual is unable to produce or use insulin well, that subsequently results in elevated blood...
Global Diabetes and
Global Diabetes and Obesity Drugs Market to reach $163.2 Billion by 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment: ResearchMoz
07 sept. 2016 08h00 HE | Researchmoz Global Pvt Ltd
Albany, NY, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Diabetes is a chronic metabolic disease characterized by hyperglycemia (high blood glucose levels) that results from defects in insulin secretion,...
Cutting Edge Information Publishes Report Forecasting DPP-4 Inhibitor Sales to Increase 450% Through 2013
21 nov. 2008 08h02 HE | Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - November 21, 2008) - A recently published therapeutic area forecasting report from pharmaceutical business intelligence leader Cutting Edge Information finds...